The Global NASH Council in the News

The GNC and GLC extend their heartfelt appreciation to Diane Langenbacher and Nikos Dedes for their outstanding leadership as co-chairs of the Patient Advocacy Committee over the past several years. Their dedication has been instrumental in ensuring that the patient voice remains central to all our initiatives, and we are deeply grateful for their contributions....Continue reading→

This year’s annual ALEH meeting in Lima, Peru features a highly scientific and exciting program. The Global NASH/MASH Council (GNC) and Global Liver Council (GLC) are proud to partner with ALEH to address key topics related to MASLD in Latin America. The GNC/GLC session is scheduled for September 30, 2025, from 15:00 to 17:30.Continue reading→

The global burden of MASLD and MASH is particularly high in the Middle East and North Africa. A recent study published in Liver International by the Global NASH/MASH Council (GNC) provides updated estimates of this regional burden.

People with metabolic dysfunction-associated fatty liver disease (MASLD) benefit from physical activity. But incorporating regular physical activity into the daily routines of patients with MASLD can be challenging due to time limitations and accessibility issues. These challenges are further compounded by the fatigue associated with MASLD. To support individuals with MASLD in initiating and maintaining...Continue reading→

Members of the Global NASH/MASH Council (GNC) are helping reframe Steatotic Liver Disease as a dynamic and evolving spectrum. In a recently published letter, Drs. Zobair M. Younossi, Shira Zelber-Sagi and Aleksander Krag share their expert insights on the future of this significant liver disease. Their perspective highlights the urgent need for a unified approach...Continue reading→

The Global NASH/MASH Council (GNC) convened a highly productive meeting during the 33rd Annual Conference of the Indian National Association for the Study of the Liver (INASL), held August 7–10, 2025, in Chandigarh, India. Focusing on the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH) in South and Southeast Asia,...Continue reading→

The Global NASH/MASH Council is delighted to collaborate with Dimer Diabetes 2025 which is a scientific meeting in Bodrum, Turkey with exceptional faculty and agenda. For more information about Dimer Diabetes 2025, please use the following link. https://www.dimerdiabetescenter.com/

GNC and GLC had another very successful meeting during ILC 2025 with over 70 members participating. The meeting was full of exciting reports related to the projects of different GNC/GLC committees. Additionally, an in-depth 3 hours meeting was dedicated to MASLD/SLD discussing NIT algorithms in clinical practice, awareness challenges, patient perspective about MASLD, preventive hepatology...Continue reading→

The Global NASH/MASH Council (GNC) has just published in Gastroenterology (April 11, 2025, In Press) the most comprehensive recommendations about MASLD and MASH. After systematically reviewing 61 guidelines and similar documents (2018-2025) and undertaking an extensive Delphi process, the Global Recommendations for MASLD/MASH provide the most updated clinically relevant information on all aspects of MASLD/MASH including risk...Continue reading→

The Global NASH/MASH Council (GNC) meeting was held during APASL 2025 in Beijing, China. The meeting was co-chaired by Professor Zobair M. Younossi and Professor Jiangao Fan and was attended by over 50 members in person and another 12 via zoom. A number of important topics related to the disease burden, NITs, risk stratification and...Continue reading→